Compare $CLYM vs $SGMT | Chartloom

Compare

$CLYM vs $SGMT

Climb Bio Inc · Sagimet Biosciences Inc

CLYM

Climb Bio Inc

SGMT

Sagimet Biosciences Inc

Compare $CLYM vs $SGMT

Comparing Climb Bio Inc and Sagimet Biosciences Inc

CLYMClimb Bio Inc

SGMTSagimet Biosciences Inc

CLYMClimb Bio Inc

Market cap

$630M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

193.3%

52W performance

511.1%

FCF yield

-8.4%

SGMTSagimet Biosciences Inc

Market cap

$551M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

194.48x

Rev growth (TTM)

—

YTD performance

49.1%

52W performance

22.2%

FCF yield

-7.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CLYM

SGMT

Detailed metrics comparison

CLYM

Climb Bio Inc

SGMT

Sagimet Biosciences Inc

Market Cap

CLYM$630M

SGMT$551M

Enterprise Value

CLYM$586M

SGMT$386M

Price

CLYM$11.00

SGMT$8.93

P/E Ratio

CLYMN/A

SGMTN/A

P/S Ratio

CLYM0.00x

SGMT0.00x

EV/Sales

CLYM0.00x

SGMT0.00x

EV/EBITDA

CLYM0.00x

SGMT0.00x

P/B Ratio

CLYM2.62x

SGMT2.20x

P/FCF Ratio

CLYMN/A

SGMTN/A

EV/FCF

CLYM-11.04x

SGMT-9.24x

PEG Ratio

CLYMN/A

SGMTN/A

Forward P/E (NTM)

CLYMN/A

SGMTN/A

Forward P/S (NTM)

CLYMN/A

SGMT194.48x

Revenue (TTM)

CLYM$0

SGMT$0

Revenue Growth (YoY)

CLYMN/A

SGMTN/A

Forward Rev Growth

CLYM27.3%

SGMT89.0%

Gross Margin (TTM)

CLYM0.0%

SGMT0.0%

Operating Margin (TTM)

CLYM0.0%

SGMT0.0%

EBITDA Margin (TTM)

CLYM0.0%

SGMT0.0%

Net Margin (TTM)

CLYM0.0%

SGMT0.0%

FCF Margin (TTM)

CLYMN/A

SGMTN/A

Net Income (TTM)

CLYM$-58M

SGMT$-47M

FCF (TTM)

CLYM$-53M

SGMT$-42M

EPS (TTM)

CLYM-$0.76

SGMT-$0.89

ROE (TTM)

CLYM-3179.0%

SGMT-3196.0%

ROA (TTM)

CLYM-3079.0%

SGMT-3057.0%

ROIC (TTM)

CLYM-3179.0%

SGMT-3196.0%

Cash

CLYM$44M

SGMT$166M

Debt

CLYM$0

SGMT$0

Net Cash/Debt

CLYM$44M

SGMT$166M

Current Ratio (TTM)

CLYM31.45x

SGMT45.02x

Quick Ratio (TTM)

CLYM30.86x

SGMT44.43x

Debt/Equity (TTM)

CLYM0.00x

SGMT0.00x

Debt/Assets (TTM)

CLYM0.0%

SGMT0.0%

Interest Coverage (TTM)

CLYMN/A

SGMTN/A

Net Debt/EBITDA (TTM)

CLYM0.00x

SGMT0.00x

Beta

CLYM-0.01

SGMT3.54

52W Performance

CLYM511.1%

SGMT22.2%

YTD Performance

CLYM193.3%

SGMT49.1%

% from 52W High

CLYM-40.0%

SGMT-22.0%

% from 52W Low

CLYM572.8%

SGMT98.4%

Asset Turnover (TTM)

CLYM0.00x

SGMT0.00x

FCF Yield (TTM)

CLYM-8.4%

SGMT-7.6%

Earnings Yield (TTM)

CLYM-9.1%

SGMT-8.5%

Dividend Yield (TTM)

CLYMN/A

SGMTN/A

Rule of 40

CLYM0.0

SGMT0.0

EV/GP/RG

CLYMN/A

SGMTN/A

Ticker research

View CLYM research View SGMT research

Metric	CLYM Climb Bio Inc	SGMT Sagimet Biosciences Inc
Market & Valuation
Market Cap	$630M	$551M
Enterprise Value	$586M	$386M
Price	$11.00	$8.93
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.62x	2.20x
P/FCF Ratio	N/A	N/A
EV/FCF	-11.04x	-9.24x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	194.48x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	27.3%	89.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-58M	$-47M
FCF (TTM)	$-53M	$-42M
EPS (TTM)	-$0.76	-$0.89
ROE (TTM)	-3179.0%	-3196.0%
ROA (TTM)	-3079.0%	-3057.0%
ROIC (TTM)	-3179.0%	-3196.0%
Financial Health
Cash	$44M	$166M
Debt	$0	$0
Net Cash/Debt	$44M	$166M
Current Ratio (TTM)	31.45x	45.02x
Quick Ratio (TTM)	30.86x	44.43x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.01	3.54
52W Performance	511.1%	22.2%
YTD Performance	193.3%	49.1%
% from 52W High	-40.0%	-22.0%
% from 52W Low	572.8%	98.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-8.4%	-7.6%
Earnings Yield (TTM)	-9.1%	-8.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CLYM research	View SGMT research

Valuation

P/S Ratio

CLYM

0.00x

SGMT

0.00x

EV/FCF

CLYM

-11.04x

SGMT

-9.24x

Growth & revenue

Forward Revenue Growth

SGMT

89.0%

CLYM

27.3%

Profitability & performance

Gross Margin

CLYM

0.0%

SGMT

0.0%

ROE

CLYM

-3179.0%

SGMT

-3196.0%

FCF Yield %

SGMT

-7.6%

CLYM

-8.4%

52-Week Performance

CLYM

511.1%

SGMT

22.2%

Detailed metrics comparison

CLYM

Climb Bio Inc

SGMT

Sagimet Biosciences Inc

Market Cap

CLYM$630M

SGMT$551M

Enterprise Value

CLYM$586M

SGMT$386M

Price

CLYM$11.00

SGMT$8.93

P/E Ratio

CLYMN/A

SGMTN/A

P/S Ratio

CLYM0.00x

SGMT0.00x

EV/Sales

CLYM0.00x

SGMT0.00x

EV/EBITDA

CLYM0.00x

SGMT0.00x

P/B Ratio

CLYM2.62x

SGMT2.20x

P/FCF Ratio

CLYMN/A

SGMTN/A

EV/FCF

CLYM-11.04x

SGMT-9.24x

PEG Ratio

CLYMN/A

SGMTN/A

Forward P/E (NTM)

CLYMN/A

SGMTN/A

Forward P/S (NTM)

CLYMN/A

SGMT194.48x

Revenue (TTM)

CLYM$0

SGMT$0

Revenue Growth (YoY)

CLYMN/A

SGMTN/A

Forward Rev Growth

CLYM27.3%

SGMT89.0%

Gross Margin (TTM)

CLYM0.0%

SGMT0.0%

Operating Margin (TTM)

CLYM0.0%

SGMT0.0%

EBITDA Margin (TTM)

CLYM0.0%

SGMT0.0%

Net Margin (TTM)

CLYM0.0%

SGMT0.0%

FCF Margin (TTM)

CLYMN/A

SGMTN/A

Net Income (TTM)

CLYM$-58M

SGMT$-47M

FCF (TTM)

CLYM$-53M

SGMT$-42M

EPS (TTM)

CLYM-$0.76

SGMT-$0.89

ROE (TTM)

CLYM-3179.0%

SGMT-3196.0%

ROA (TTM)

CLYM-3079.0%

SGMT-3057.0%

ROIC (TTM)

CLYM-3179.0%

SGMT-3196.0%

Cash

CLYM$44M

SGMT$166M

Debt

CLYM$0

SGMT$0

Net Cash/Debt

CLYM$44M

SGMT$166M

Current Ratio (TTM)

CLYM31.45x

SGMT45.02x

Quick Ratio (TTM)

CLYM30.86x

SGMT44.43x

Debt/Equity (TTM)

CLYM0.00x

SGMT0.00x

Debt/Assets (TTM)

CLYM0.0%

SGMT0.0%

Interest Coverage (TTM)

CLYMN/A

SGMTN/A

Net Debt/EBITDA (TTM)

CLYM0.00x

SGMT0.00x

Beta

CLYM-0.01

SGMT3.54

52W Performance

CLYM511.1%

SGMT22.2%

YTD Performance

CLYM193.3%

SGMT49.1%

% from 52W High

CLYM-40.0%

SGMT-22.0%

% from 52W Low

CLYM572.8%

SGMT98.4%

Asset Turnover (TTM)

CLYM0.00x

SGMT0.00x

FCF Yield (TTM)

CLYM-8.4%

SGMT-7.6%

Earnings Yield (TTM)

CLYM-9.1%

SGMT-8.5%

Dividend Yield (TTM)

CLYMN/A

SGMTN/A

Rule of 40

CLYM0.0

SGMT0.0

EV/GP/RG

CLYMN/A

SGMTN/A

Ticker research

View CLYM research View SGMT research

Metric	CLYM Climb Bio Inc	SGMT Sagimet Biosciences Inc
Market & Valuation
Market Cap	$630M	$551M
Enterprise Value	$586M	$386M
Price	$11.00	$8.93
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.62x	2.20x
P/FCF Ratio	N/A	N/A
EV/FCF	-11.04x	-9.24x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	194.48x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	27.3%	89.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-58M	$-47M
FCF (TTM)	$-53M	$-42M
EPS (TTM)	-$0.76	-$0.89
ROE (TTM)	-3179.0%	-3196.0%
ROA (TTM)	-3079.0%	-3057.0%
ROIC (TTM)	-3179.0%	-3196.0%
Financial Health
Cash	$44M	$166M
Debt	$0	$0
Net Cash/Debt	$44M	$166M
Current Ratio (TTM)	31.45x	45.02x
Quick Ratio (TTM)	30.86x	44.43x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.01	3.54
52W Performance	511.1%	22.2%
YTD Performance	193.3%	49.1%
% from 52W High	-40.0%	-22.0%
% from 52W Low	572.8%	98.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-8.4%	-7.6%
Earnings Yield (TTM)	-9.1%	-8.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CLYM research	View SGMT research